BIOMAT Database Logo BIOMAT Database Logo

In vitro selection of RNA aptamers that can bind specifically to Tat protein of HIV-1. 1995

R Yamamoto, and S Toyoda, and P Viljanen, and K Machida, and S Nishikawa, and K Murakami, and K Taira, and P K Kumar
Institute of Applied Biochemistry, University of Tsukuba, Japan.

The Tat protein of human immunodeficiency virus interacts specifically with its target RNA sequence, TAR, and activates viral gene expression at the early stage of infection. Here, we have used in vitro genetic selection strategy to determine what sequence or structural motifs might exist between RNA's that interact specifically with the Tat protein. Starting from a RNA pool that has a 120 base random sequence core, aptamers that bind specifically to the Tat protein were selected by repeating 11 rounds of selection and amplification. A comparative analysis of 64 aptamers that were isolated from the 11th generation revealed two main sequence classes. Interestingly, one of these two classes of aptamers had minimum of one U residues in bulge loop and 2 specific adjacent base pairs. This region is very much homologous to the core sequence of TAR RNA that is essential for the specific Tat-TAR interactions. Further analyses of the sequences from the 11th generation should reveal what kind of RNA structures are required in order to show a high affinity for the Tat protein.

UI MeSH Term Description Entries
D008969 Molecular Sequence Data Descriptions of specific amino acid, carbohydrate, or nucleotide sequences which have appeared in the published literature and/or are deposited in and maintained by databanks such as GENBANK, European Molecular Biology Laboratory (EMBL), National Biomedical Research Foundation (NBRF), or other sequence repositories. Sequence Data, Molecular,Molecular Sequencing Data,Data, Molecular Sequence,Data, Molecular Sequencing,Sequencing Data, Molecular
D009690 Nucleic Acid Conformation The spatial arrangement of the atoms of a nucleic acid or polynucleotide that results in its characteristic 3-dimensional shape. DNA Conformation,RNA Conformation,Conformation, DNA,Conformation, Nucleic Acid,Conformation, RNA,Conformations, DNA,Conformations, Nucleic Acid,Conformations, RNA,DNA Conformations,Nucleic Acid Conformations,RNA Conformations
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D001483 Base Sequence The sequence of PURINES and PYRIMIDINES in nucleic acids and polynucleotides. It is also called nucleotide sequence. DNA Sequence,Nucleotide Sequence,RNA Sequence,DNA Sequences,Base Sequences,Nucleotide Sequences,RNA Sequences,Sequence, Base,Sequence, DNA,Sequence, Nucleotide,Sequence, RNA,Sequences, Base,Sequences, DNA,Sequences, Nucleotide,Sequences, RNA
D001665 Binding Sites The parts of a macromolecule that directly participate in its specific combination with another molecule. Combining Site,Binding Site,Combining Sites,Site, Binding,Site, Combining,Sites, Binding,Sites, Combining
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D015497 HIV-1 The type species of LENTIVIRUS and the etiologic agent of AIDS. It is characterized by its cytopathic effect and affinity for the T4-lymphocyte. Human immunodeficiency virus 1,HIV-I,Human Immunodeficiency Virus Type 1,Immunodeficiency Virus Type 1, Human
D015696 Gene Products, tat Trans-acting transcription factors produced by retroviruses such as HIV. They are nuclear proteins whose expression is required for viral replication. The tat protein stimulates LONG TERMINAL REPEAT-driven RNA synthesis for both viral regulatory and viral structural proteins. Tat stands for trans-activation of transcription. tat Gene Products,tat Protein,Gene Product, tat,tat Gene Product
D054322 tat Gene Products, Human Immunodeficiency Virus Proteins encoded by the TAT GENES of the HUMAN IMMUNODEFICIENCY VIRUS. HIV Transacting Transcription Protein,HIV tat Protein,Trans-Acting Transcription Factor, HIV,Trans Acting Transcription Factor, HIV,tat Protein, HIV
D066298 In Vitro Techniques Methods to study reactions or processes taking place in an artificial environment outside the living organism. In Vitro Test,In Vitro Testing,In Vitro Tests,In Vitro as Topic,In Vitro,In Vitro Technique,In Vitro Testings,Technique, In Vitro,Techniques, In Vitro,Test, In Vitro,Testing, In Vitro,Testings, In Vitro,Tests, In Vitro,Vitro Testing, In

Related Publications

R Yamamoto, and S Toyoda, and P Viljanen, and K Machida, and S Nishikawa, and K Murakami, and K Taira, and P K Kumar
Fragments of the HIV-1 Tat protein specifically bind TAR RNA.
September 1990, Science (New York, N.Y.),
R Yamamoto, and S Toyoda, and P Viljanen, and K Machida, and S Nishikawa, and K Murakami, and K Taira, and P K Kumar
Fragments of the HIV-Tat protein specifically bind TAR RNA.
January 1991, Disease markers,
R Yamamoto, and S Toyoda, and P Viljanen, and K Machida, and S Nishikawa, and K Murakami, and K Taira, and P K Kumar
In vitro selection of RNA aptamers that selectively bind danofloxacin.
June 2014, Biochemical and biophysical research communications,
R Yamamoto, and S Toyoda, and P Viljanen, and K Machida, and S Nishikawa, and K Murakami, and K Taira, and P K Kumar
Selection of RNA aptamers that bind HIV-1 LTR DNA duplexes: strand invaders.
December 2010, Nucleic acids research,
R Yamamoto, and S Toyoda, and P Viljanen, and K Machida, and S Nishikawa, and K Murakami, and K Taira, and P K Kumar
RNA aptamers that specifically bind to the Ras-binding domain of Raf-1.
December 1998, FEBS letters,
R Yamamoto, and S Toyoda, and P Viljanen, and K Machida, and S Nishikawa, and K Murakami, and K Taira, and P K Kumar
Selection of RNA aptamers that bind specifically to the NS3 protease of hepatitis C virus.
August 1997, European journal of biochemistry,
R Yamamoto, and S Toyoda, and P Viljanen, and K Machida, and S Nishikawa, and K Murakami, and K Taira, and P K Kumar
In vitro selection of RNA aptamers that bind to domain II of HCV IRES.
January 2002, Nucleic acids research. Supplement (2001),
R Yamamoto, and S Toyoda, and P Viljanen, and K Machida, and S Nishikawa, and K Murakami, and K Taira, and P K Kumar
RNA aptamers that specifically bind to a 16S ribosomal RNA decoding region construct.
August 2000, Nucleic acids research,
R Yamamoto, and S Toyoda, and P Viljanen, and K Machida, and S Nishikawa, and K Murakami, and K Taira, and P K Kumar
RNA aptamers that specifically bind to a K Ras-derived farnesylated peptide.
June 1997, Bioorganic & medicinal chemistry,
R Yamamoto, and S Toyoda, and P Viljanen, and K Machida, and S Nishikawa, and K Murakami, and K Taira, and P K Kumar
In vitro selection of aptamers that bind to ribosome-inactivating toxins.
January 1997, Nucleic acids symposium series,
Copied contents to your clipboard!